プロフィール詳細

プロジェクトを作成

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Dr. Stephanie S.に依頼

United Kingdom

Science writing, editing, consulting & social media management with 10+years experience in cancer, immunotherapy, viruses & more

プロフィール概要

We are a small, independent boutique research company providing freelance writing, editing, proofreading, consultancy and social media profile management services in medical, scientific, academic and industry research fields. We have over ten years of pre-clinical and clinical experience in writing and editing for healthcare, medicine, the life sciences, the natural sciences and more. We offer particular expertise in the fields of cancer, immunotherapy, neoantigens, personalised medicine, vaccines, virology, immunology, genomics and oncolytic virus research.

専門分野

• ★ Vaccine Development
• ★ Immunotherapy
• ★ Cancer Research
• ☆ Virology
• ☆ Molecular Virology
• ☆ Molecular Biology
• ☆ Genetics
• ☆ Oncology
• ☆ Clinical Pathology
• ☆ Molecular Pathology
• ☆ Literature Review
• ☆ Systematic Literature Review

サービス

• Writing
• Research
• Consulting
• Data & AI
• Product Development

Writing Clinical Trial Documentation, Technical Writing, Copywriting, Newswriting

Research Feasibility Study, Fact Checking, Gray Literature Search, Systematic Literature Review, Secondary Data Collection

Consulting Scientific and Technical Consulting

Data & AI Statistical Analysis, Data Visualization

Product Development Formulation

職務経験

Consultant in Systematic Reviews and Evidence Synthesis

Mtech Access

11月 2020 - 現在

Systematic Reviewer

Kleijnen Systematic Reviews Ltd

5月 2017 - 現在

Director

Swift Science Writing

2012 - 現在

Science Writer

Children's Hospital of Eastern Ontario Research Institute

11月 2013 - 4月 2017

Clinical Trials Manager

McMaster University Faculty of Health Sciences

1月 2009 - 10月 2013

学歴

Ph.D in Biology

University of York

9月 2004 - 9月 2008

BSc. (Hons) in Bioveterinary Medicine

University of Liverpool

9月 2001 - 6月 2004

認定資格

• 認定資格の詳細は未入力です。

出版物

JOURNAL ARTICLE

(2019). Effect of {DNA} damage response mutations on prostate cancer prognosis: a systematic review . Future Oncology. 15. (28). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 3283--3303. Future Medicine Ltd

(2019). A systematic review of the prevalence of {DNA} damage response gene mutations in prostate cancer . International Journal of Oncology. Spandidos Publications

(2019). Systematic review and network meta-analysis of the efficacy and safety of lidocaine 700{\hspace{0.167em}}mg medicated plaster vs. pregabalin . Current Medical Research and Opinion. 36. (1). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 101--115. Informa {UK} Limited

Balathasan L, Tang VA, Yadollahi B, Brun J, Labelle M, Lefebvre C, Swift SL, Stojdl DF(2017). Activating Peripheral Innate Immunity Enables Safe and Effective Oncolytic Virotherapy in the Brain . Molecular Therapy Oncolytics.

Bramlage P, Swift SL, Thoenes M, Minguet J, Ferrero C, Schmieder RE(2017). Non-steroidal mineralocorticoid receptor antagonism for the treatment of cardiovascular and renal disease . European journal of heart failure.

Anipindi VC, Bagri P, Roth K, Dizzell SE, Nguyen PV, Shaler CR, Chu DK, Jiménez-Saiz R, Liang H, Swift S, et al.(2016). Estradiol Enhances CD4+ T-Cell Anti-Viral Immunity by Priming Vaginal DCs to Induce Th17 Responses via an IL-1-Dependent Pathway . PLoS pathogens.

Bridle BW, Nguyen A, Salem O, Zhang L, Koshy S, Clouthier D, Chen L, Pol J, Swift SL, Bowdish DM, et al.(2016). Privileged Antigen Presentation in Splenic B Cell Follicles Maximizes T Cell Responses in Prime-Boost Vaccination . Journal of immunology (Baltimore, Md. : 1950).

Allan KJ, Stojdl DF, Swift SL(2016). High-throughput screening to enhance oncolytic virus immunotherapy . Oncolytic virotherapy.

Swift SL, Stojdl DF(2016). Big Data Offers Novel Insights for Oncolytic Virus Immunotherapy . Viruses.

Bramlage P, Swift SL, Thoenes M, Minguet J, Ferrero C, Schmieder RE(2015). Non-steroidal mineralocorticoid receptor antagonism for the treatment of cardiovascular and renal disease . European journal of heart failure.

Ilkow CS, Swift SL, Bell JC, Diallo JS(2014). From scourge to cure: tumour-selective viral pathogenesis as a new strategy against cancer . PLoS pathogens.

McGray AJ, Hallett R, Bernard D, Swift SL, Zhu Z, Teoderascu F, Vanseggelen H, Hassell JA, Hurwitz AA, Wan Y, et al.(2013). Immunotherapy-induced CD8+ T cells instigate immune suppression in the tumor . Molecular therapy : the journal of the American Society of Gene Therapy.

Bassett JD, Swift SL, VanSeggelen H, Hammill JA, McGray AJ, Evelegh C, Wan Y, Bramson JL(2011). Combined mTOR inhibition and OX40 agonism enhances CD8(+) T cell memory and protective immunity produced by recombinant adenovirus vaccines . Molecular therapy : the journal of the American Society of Gene Therapy.

Bassett JD, Swift SL, Bramson JL(2011). Optimizing vaccine-induced CD8(+) T-cell immunity: focus on recombinant adenovirus vectors . Expert review of vaccines.

Rivera-Gonzalez GC, Swift SL, Dussupt V, Georgopoulos LJ, Maitland NJ(2011). Baculoviruses as gene therapy vectors for human prostate cancer . Journal of invertebrate pathology.

Bassett JD, Yang TC, Bernard D, Millar JB, Swift SL, McGray AJ, VanSeggelen H, Boudreau JE, Finn JD, Parsons R, et al.(2010). CD8+ T-cell expansion and maintenance after recombinant adenovirus immunization rely upon cooperation between hematopoietic and nonhematopoietic antigen-presenting cells . Blood.